HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

XL-001

Also Known As:

N-((4-(diethylamino)phenyl)methyl)-4-methoxy-N-(4-methylphenyl)benzenesulfonamide

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Feng, Zhiwei: 1 article (10/2018)
2.	Liu, Youhua: 1 article (10/2018)
3.	Tian, Yuan: 1 article (10/2018)
4.	Xie, Xiang-Qun: 1 article (10/2018)
5.	Yang, Peng: 1 article (10/2018)
6.	Zhou, Lili: 1 article (10/2018)
7.	Zhou, Shan: 1 article (10/2018)

Related Diseases

1.	Inflammation (Inflammations) 10/01/2018 - "Delayed administration of XL-001 was also effective in ameliorating kidney fibrosis and inflammation. " 10/01/2018 - "In vivo, intraperitoneal injections of XL-001 ameliorated kidney injury, fibrosis and inflammation in both the obstruction and ischemia/reperfusion models. "
2.	Fibrosis (Cirrhosis) 10/01/2018 - "Delayed administration of XL-001 was also effective in ameliorating kidney fibrosis and inflammation. " 10/01/2018 - "Thus, CB2 is a pathogenic mediator in kidney fibrosis and targeted inhibition with the novel inverse agonist XL-001 may provide a strategy in the fight against fibrotic kidney diseases." 10/01/2018 - "In vivo, intraperitoneal injections of XL-001 ameliorated kidney injury, fibrosis and inflammation in both the obstruction and ischemia/reperfusion models. "
3.	Kidney Diseases (Kidney Disease) 10/01/2018 - "Thus, CB2 is a pathogenic mediator in kidney fibrosis and targeted inhibition with the novel inverse agonist XL-001 may provide a strategy in the fight against fibrotic kidney diseases."
4.	Ischemia 10/01/2018 - "In vivo, intraperitoneal injections of XL-001 ameliorated kidney injury, fibrosis and inflammation in both the obstruction and ischemia/reperfusion models. "

Related Therapies and Procedures

1.	Intraperitoneal Injections